Panlong Pharmaceutical announced that after self-inspection, the company and its holding subsidiaries have accumulated supplementary tax payments of 14.15,800 yuan and late payment fees of 2,547,900 yuan this year, totaling 16.6986 million yuan in supplementary taxes and late fees, accounting for 17.34% of the company's audited net profit for the most recent fiscal year. There are no administrative penalties involved in this supplementary payment. As of the disclosure date of the announcement, all of the above taxes and late fees have been paid. This matter is not an early accounting error. It does not involve a retroactive adjustment of the financial data for the previous period. The relevant amount is included in current profit and loss in 2026 and will not affect the normal operation of the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.